Joy Parijat Saurav, Kumar Gagan, Poole Jeanne E, London Barry, Olshansky Brian
University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Northeast Georgia Health System, Gainesville, Georgia.
Heart Rhythm. 2017 Jun;14(6):839-845. doi: 10.1016/j.hrthm.2017.03.019. Epub 2017 Mar 16.
Cardiac implantable electronic device (CIED) infections are associated with hospitalization, mortality, increased costs, and adverse outcomes.
Determine the burden of infections for CIEDs based on device type, associated comorbidities, and clinical characteristics over a 12-year period.
Utilizing data from the National Inpatient Sample database for cases from 2000 through 2012, we identified procedures for device-related infection (DRI) using International Statistical Classification of Diseases and Related Health Problems, Ninth Revision, Clinical Modification (ICD-9-CM) codes for CIED removal with diagnosis codes for device-related infection or systemic infection. Cases were categorized into 4 groups: single-chamber pacemaker, dual-chamber pacemaker, cardiac resynchronization therapy (CRT) device, and intracardiac defibrillator (ICD).
Of 4,144,683 device-related procedures, 85,203 (2.06%) were associated with DRI. From 2000 through 2012, procedures related to DRI increased from 1.45% to 3.41% (P < .001). The risk of infection for CRT devices was the highest, peaking in 2012 (adjusted odds ratio [OR] 2.43, P < .001). During second half of the study, comorbidities associated with DRI were diabetes (OR: 1.11, P < .001), end-stage renal disease (OR: 3.23, P < .001), hematoma (OR: 2.44, P < .001), malnutrition (OR: 2.66, P < .001), venous thromboembolism (OR: 2.37, P < .001), chronic kidney disease (OR: 1.26, P < .001), and organ transplantation (OR: 2.37, P < .001). Charges associated with CRT DRIs increased nearly 2-fold in a decade. Higher inpatient mortality related to device infection were stroke (OR: 3.19, P < .001), end-stage renal disease (OR: 2.91, P < .001), malnutrition (OR: 2.67, P < .001), cirrhosis (OR: 2.05, P = .001), and organ transplantation (OR: 2.16, P < .001).
CIED infections are increasing for all device types and particularly for CRT devices. Precise reasons for rising DRI procedures remain unclear, although conditions leading to immune compromise appear significant.
心脏植入式电子设备(CIED)感染与住院、死亡率、成本增加及不良后果相关。
确定基于设备类型、相关合并症及临床特征的12年间CIED感染负担。
利用2000年至2012年国家住院样本数据库的数据,我们使用国际疾病分类及相关健康问题第九版临床修订本(ICD-9-CM)编码来识别与设备相关感染(DRI)的程序,这些编码用于CIED移除且带有与设备相关感染或全身感染的诊断编码。病例分为4组:单腔起搏器、双腔起搏器、心脏再同步治疗(CRT)设备及植入式心脏除颤器(ICD)。
在4,144,683例与设备相关的手术中,85,203例(2.06%)与DRI相关。从2000年到2012年,与DRI相关的手术从1.45%增至3.41%(P <.001)。CRT设备的感染风险最高,在2012年达到峰值(调整后的优势比[OR]为2.43,P <.001)。在研究的后半期,与DRI相关的合并症有糖尿病(OR:1.11,P <.001)、终末期肾病(OR:3.23,P <.001)、血肿(OR:2.44,P <.001)、营养不良(OR:2.66,P <.001)、静脉血栓栓塞(OR:2.37,P <.001)、慢性肾病(OR:1.26,P <.001)及器官移植(OR:2.37,P <.001)。与CRT DRI相关的费用在十年内增加了近两倍。与设备感染相关的较高住院死亡率的情况有中风(OR:3.19,P <.001)、终末期肾病(OR:2.91,P <.001)、营养不良(OR:2.67,P <.001)、肝硬化(OR:2.05,P =.001)及器官移植(OR:2.16,P <.001)。
所有设备类型的CIED感染都在增加,尤其是CRT设备。尽管导致免疫功能受损的情况似乎很重要,但DRI手术增加的确切原因仍不清楚。